. 2019 Jul 26;8(15):e012093. doi: 10.1161/JAHA.119.012093

Table 3.

Details of Cases of Morphologic Abnormalities

Case	Group	Birth Defects	Age at Delivery/Underlying Disease	Delivery Outcome	Superimposed Preeclampsia	Antihypertensive Agents		Other Drugs
1	A	PVS	41 y.o. Essential hypertension	35w4d 1872 g	−	Prepregnancy to 4w6d	Am	12w0d to 28w0d: LDA
						34w5d to 35w0d	Me
						35w1d to delivery	Me, Nif
2	A	VSD	36 y.o. Primary aldosteronism	38w0d 3217 g	−	Prepregnancy to 6w4d	Am	8w3d to 28w0d: LDA
						6w5d to 8w0d	Hy
						8w1d to delivery	Am
3	O	Low‐lying conus medullaris/hypospadias/inguinal hernia	42 y.o. Essential hypertension	29w1d 521 g	+	Prepregnancy to 8w2d	La	12w6d to delivery: LDA
						9w4d to 12w0d	Me
						12w1d to 12w5d	Me, La
						12w6d to 17w5d	Me, La, Am
						17w6d to delivery	Me, Am
4	O	VSD	38 y.o. Essential hypertension RA	25w6d 382 g	−	Prepregnancy to delivery	Nic, La	Prepregnancy to delivery: PSL 3w to delivery: LDA
5	O	Hypospadias	39 y.o. Essential hypertension	39w4d 2912 g	+	8w4d to 30w2d	Me	None
5	O	Hypospadias	39 y.o. Essential hypertension	39w4d 2912 g	+	30w3d to delivery	Me, Am	None
6	N	Hypospadias	33 y.o. Essential hypertension	27w1d 506 g	+	13w2d to 18w2d	Hy	12w0d to delivery: LDA
6	N	Hypospadias	33 y.o. Essential hypertension	27w1d 506 g	+	18w2d to delivery	La	12w0d to delivery: LDA
7	N	Patent foramen ovale/low‐lying conus medullaris	40 y.o. Essential hypertension	35w4d 1351 g	+	16w0d to 24w6d	Me	None
7	N	Patent foramen ovale/low‐lying conus medullaris	40 y.o. Essential hypertension	35w4d 1351 g	+	25w0d to delivery	Me, Nif	None
8	N	Low anorectal anomaly/low‐lying conus medullaris	42 y.o. Essential hypertension	26w0d 379 g	+	21w0d to 21w1d	Me	None
8	N	Low anorectal anomaly/low‐lying conus medullaris	42 y.o. Essential hypertension	26w0d 379 g	+	21w2d to delivery	Me, Am	None
9	N	Low‐lying conus medullaris	37 y.o. Essential hypertension	34w3d 2108 g	−	16w4d to 28w5d	Me	None
9	N	Low‐lying conus medullaris	37 y.o. Essential hypertension	34w3d 2108 g	−	28w6d to delivery	Me, Am	None
10	N	Potter syndrome	40 y.o. Essential hypertension	33w6d 1836 g	−	None		None
11	N	Colpocephaly	32 y.o. Essential hypertension	40w4d 3396 g	−	None		None

A indicates amlodipine group; Am, amlodipine; Hy, hydralazine; La, labetalol; LDA, low‐dose aspirin; Me, methyldopa; N, No antihypertensive group; Nic, nicardipine; Nif, nifedipine; O, Other antihypertensive group; PSL, prednisolone; PVS, pulmonary valve stenosis; RA, rheumatoid arthritis; VSD, ventricular septal defect; y.o., years old.